Active Shortage

TARO-BORTEZOMIB

TARO PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TARO-BORTEZOMIB in Canada?

Yes. TARO-BORTEZOMIB 2.5MG has an active shortage reported to Health Canada (last updated August 17, 2026).

Why is TARO-BORTEZOMIB not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will TARO-BORTEZOMIB be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file5 products · 4 same form & route

Affected strength2.5MG

Report last updated2026-08-17

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

BORTEZOMIB INJECTION

DR REDDY'S LABORATORIES LTD

2.5MG · DIN 02550075

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

BORTEZOMIB

APOTEX INC

3.5MG · DIN 02456176

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-BORTEZOMIB

PHARMASCIENCE INC

3.5MG · DIN 02466708

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TARO-BORTEZOMIB

TARO PHARMACEUTICALS INC

3.5MG · DIN 02499061

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

VELCADE

JANSSEN INC

3.5MG · DIN 02262452

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02511932

Strength

2.5MG

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS

Active Ingredient

BORTEZOMIB

Tier

Unrated

Last Updated

2026-08-17

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from TARO PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ANTI-ITCH CREAM

2% · DIN 02247560

ANTIBIOTIC CREAM FOR KIDS

DIN 02315033

ANTIBIOTIC OINTMENT USP

DIN 02230251

ANTIBIOTIC PLUS PAIN RELIEF CREAM

DIN 02304457

BETADERM CRM 0.05%

0.05% · DIN 00716618

BETADERM CRM 0.1%

0.1% · DIN 00716626